November 2011

University of Michigan Comprehensive Cancer CenterCancer News

Groundbreaking Research on Triple-Negative Breast Cancer Gets Boost from Komen

Breast cancer researchers at the University of Michigan recently garnered a $3.5 million grant from Susan G. Komen for the Cure® to study cancer stem cells in an aggressive subtype of breast cancer that disproportionately affects African-American women, called triple-negative breast cancer. more

New Endowment Supports Music Therapy Program

More than a thousand U-M cancer patients each year rely on the Comprehensive Cancer Center's innovative music therapy program to reduce anxiety, ease pain and nausea, and improve their quality of life during cancer treatments. Now, thanks to the vision and generosity of Bill and Dee Brehm, this program will continue to lift the spirits and wellbeing of cancer patients, in perpetuity. more

More News

Urine Test Detects Prostate Cancer Risk, U-M Study Finds

A new urine test can help aid early detection of, and treatment decisions about, prostate cancer, according to a new study conducted by U-M prostate cancer researchers. more

Researchers ID Promising Pancreatic Cancer Screening Marker

U-M pancreatic cancer researchers have identified a protein that shows distinct changes in structure between pancreatic cancer, non-cancerous diseases, and normal blood serum. more

New Cancer Drug Discovered at U-M Heads to Clinical Trials

Researchers at the U-M's Comprehensive Cancer Center have developed a new drug called AT-406, which has the potential to treat multiple types of cancer. more

Patients' Underlying Health Linked to Worse Outcomes for Melanoma

It's not how old but how frail patients are that can predict how well they will fare after a melanoma diagnosis. In fact, young patients in poor health may have worse outcomes than older patients in good shape. more

Stay Connected

TwitterFacebookYouTubemCancerTalkThrive NewsletterMedicine at Michigan magazine
 

Director's Letter

Welcome to the first issue of the new U-M cancer e-newsletter. We are excited to share with you some of the important work happening here at the Comprehensive Cancer Center to advance the treatment of cancer. more

Max S. Wicha, M.D.
The Michigan Difference

Cancer doctors featured in new Michigan Difference ads. Watch the video on liver cancer with Dr. Jorge Marrero.

Jorge A. Marrero, M.D.

Media Coverage

More media coverage…

Get Involved

ComfortApp Initiative
U-M students launch effort to provide I-Pads to cancer patients during treatment. Learn how you can help

Pike Rivalry Run, November 18 & 19
Pi Kappa Alpha Fraternity annual event to support U-M’s Coach Carr Fund Learn more

The First Annual Tim O’Brien Trivia Night, Saturday, January 28
If you like trivia, then join others at this fun event to support U-M’s Comprehensive Cancer Center Learn more

Salon Varga’s 2nd Annual Cut, Colour & Cure, Saturday, February 25
A fun night of “Reggae for Research” will have everyone dancing, while supporting breast cancer research at U-M Learn more

More events…
Plan your own event…

© 2011 The Regents of the University of Michigan Non-discrimination policy
If you'd prefer not to receive this email, click here to unsubscribe.

U-M Surgeon Travels to Africa to Find Origins of Highly Aggressive Breast Cancer

African American women have a lower lifetime incidence of breast cancer compared to white American women, yet, surprisingly, they are more likely to lose their lives to the disease. Dr. Lisa Newman, U-M professor of surgery and director of the Breast Care Center, has dedicated her career to finding out why. Her innovative research to discover the origins of a highly aggressive form of breast cancer that disproportionately affects African American women, called triple-negative breast cancer, aims to uncover links to breast cancer patients in West Africa.

Urine test detects prostate cancer risk, U-M study finds

A new urine test can help aid early detection of, and treatment decisions about, prostate cancer, according to a new study conducted by U-M prostate cancer researchers. The test supplements an elevated prostate specific antigen, or PSA, screening result, and could help some men delay or avoid a needle biopsy while pointing out men at highest risk for clinically significant prostate cancer.

Researchers ID Promising Pancreatic Cancer Screening Marker

U-M pancreatic cancer researchers have identified a protein that shows distinct changes in structure between pancreatic cancer, non-cancerous diseases, and normal blood serum. The protein also changes from early stage pancreatic cancer to advanced disease. The finding suggests a blood test could serve as a potential screening tool to detect pancreatic cancer -- which has the worst prognosis of any cancer type -- at an earlier, more treatable stage.

New Cancer Drug Discovered

Researchers at the U-M's Comprehensive Cancer Center have developed a new drug called AT-406, which has the potential to treat multiple types of cancer. U-M's study, published in the Journal of Medicinal Chemistry, showed that AT-406 effectively targets proteins that block normal cell death from occurring. Blocking these proteins caused tumor cells to die, while not harming normal cells. The researchers believe the drug could potentially be used alone or in combination with other treatments.

Groundbreaking Research

Breast cancer researchers at the University of Michigan recently garnered a $3.5 million grant from Susan G. Komen for the Cure® to study cancer stem cells in an aggressive subtype of breast cancer that disproportionately affects African-American women, called triple-negative breast cancer.

Subscribe to RSS - November 2011